Utility of serum thyroglobulin measurements after prophylactic thyroidectomy in patients with hereditary medullary thyroid cancer

Surgery. 2014 Aug;156(2):394-8. doi: 10.1016/j.surg.2014.03.037. Epub 2014 Jun 2.

Abstract

Introduction: Prophylactic thyroidectomy can be curative for patients with hereditary medullary thyroid cancer (MTC) caused by RET proto-oncogene mutations. Calcitonin is a sensitive tumor marker used to follow patients. We suggest that thyroglobulin (Tg) levels should also be monitored postoperatively in these patients.

Methods: We reviewed patients with RET mutations who underwent prophylactic thyroidectomy between 1981 and 2011 at an academic endocrine surgery center. Patients were excluded if they had no postoperative Tg levels recorded.

Results: Of the 22 patients who underwent prophylactic thyroidectomy, 14 were included in the final analysis. The average age at thyroidectomy was 9.8 years (range, 4-29). Tg levels were detectable 1.5 months to 31 years postoperatively in 11 patients (79%), all of whom were <15 years old at thyroidectomy. Median thyroid-stimulating hormone (TSH) was 2.5 mIU/L and 13.4 mIU/L in patients with undetectable and detectable Tg, respectively. Of those with detectable Tg, 5 had cervical ultrasonographic examination: Two showed no residual tissue in the thyroid bed, and 3 showed remnant thyroid tissue.

Conclusion: Tg levels can identify patients with remnant thyroid tissue after prophylactic thyroidectomy. Ultrasonography can determine whether thyroid tissue remains posterolaterally that is at risk of MTC recurrence. Maintaining normal TSH may prevent growth of remaining thyroid follicular cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Carcinoma, Medullary / blood*
  • Carcinoma, Medullary / genetics
  • Carcinoma, Medullary / surgery*
  • Carcinoma, Neuroendocrine
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Multiple Endocrine Neoplasia Type 2a / blood
  • Multiple Endocrine Neoplasia Type 2a / genetics
  • Multiple Endocrine Neoplasia Type 2a / surgery
  • Mutation
  • Neoplasm Recurrence, Local / prevention & control
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-ret / genetics
  • Thyroglobulin / blood*
  • Thyroid Neoplasms / blood*
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / surgery*
  • Thyroidectomy*
  • Thyrotropin / blood

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Thyrotropin
  • Thyroglobulin
  • Proto-Oncogene Proteins c-ret
  • RET protein, human

Supplementary concepts

  • Thyroid cancer, medullary